Friday, 03 April 2020

Generics News

  • Shasun to focus on global regulatory markets

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jun, 2014

    Singapore: Shasun pharmaceuticals an Indian pharmaceutical company, aims to focus on formulations manufacturing and marketing in the regulated markets, and become a global integrated sector...Read more

  • IOF, Fonterra grants $43K to Indonesian for bone R&D

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have come together to fund and support research on female bone health in In...Read more

  • Mylan launches generic hypertension drug in US

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2014

    Singapore: Global pharmaceutical firm, Mylan, has launched Telmisartan tablets-20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis tablets, in US. Mylan received...Read more

  • New tech promises revenue boost for drug makers

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to improve efficacy and safety of existing prescriptions and over-the-counter...Read more

  • Abbott to sell branded generics business to Mylan

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Global pharmaceutical firm Abbott is planning to sell its developed markets branded generics pharmaceuticals business to Mylan in approximately $5.3 billion. Abbott will retain ...Read more

  • Another Ranbaxy plant faces US FDA ire

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2014

    Singapore: The year 2014 is bringing back haunting memories of the way the year gone by had started for India's biggest drug maker. While 2013 started with Ranbaxy making the largest settle...Read more

  • Takeda diabetes drug gets China's import license

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 diabetes drug Nesina (alogliptin). Orally administered dipeptidyl pept...Read more

  • Dr. Reddy's launches Aricept generic Donepezil

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generic version of Aricept, 23 mg in the US market following the approval b...Read more

  • Japan pharma to grow at 2% CAGR from 2013-20

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more

  • ULURU inks pact with Japanese medical firm

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2016

    Texas-headquartered ULURU Inc has expanded its distribution network by entering into a cooperation agreement with Saraya Co Ltd for the registration of Altrazeal and further cooperation in ...Read more

  • Japan approves generic drug for osteoporosis

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

    Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (generic name) for the treatment of osteoporosis by Ajinomoto Pharmaceutic...Read more

  • Teva launches generic of cancer drug Temodar in US

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: Israel-based Teva Pharmaceutical and US-based Perrigo have launched generic version of cancer drug Temodar (temozolomide) in US. Teva will manufacture, market and distribute the...Read more

  • Taiwan firm gets ANDA approval for generics of Pfizer's Procardia

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2014

    Singapore: Taiwan's TWi Pharmaceuticals has recieved ANDA approval of the generic equivalent to Procardia XL (Nifedipine) Extended Release Tablets, 30 mg, 60 mg and 90 mg, in the United Sta...Read more

  • Takeda gets Japanese NDA approval for obesity drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labour and Welfare approval for the new drug application (NDA) of Oblean ...Read more

  • MHRA issues import alert to Wockhardt's India plant

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug quality issues, the company has run into trouble with UK's Medicines a...Read more

  • Irish firm's track-&-trace system to curb fake drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at eliminating the use of counterfeit drugs. Leading the battle against...Read more

  • Mylan launches generic version of Sporanox

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2012

    Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA) for Itraconazole Capsules, 100 mg. This product is the generic versi...Read more

  • Daiichi Sankyo, Ranbaxy to leverage synergies in Thailand

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand, to leverage and maximize the synergies of the Hybrid Business Model...Read more